Premenstrual dysphoric disorder (PMDD)
- SSRIs are first-line pharmacotherapy
- Continuous or luteal-phase dosing both work
- Drospirenone-containing COC is another option
- CBT/exercise can be useful adjuncts
- Confirm cyclic symptom pattern prospectively
- Refractory severe disease may need ovarian suppression
Use at a glance
- SSRIs are first-line pharmacotherapy
Practical pearls
- Continuous or luteal-phase dosing both work
- Drospirenone-containing COC is another option
Other practical pearls
- CBT/exercise can be useful adjuncts
- Confirm cyclic symptom pattern prospectively
Escalation / refractory disease
- Refractory severe disease may need ovarian suppression
Self-check
- What should be confirmed before treating Premenstrual dysphoric disorder (PMDD)?
cyclic symptom pattern prospectively.
Drugs used for this (1)
All clinical uses · Open the interactive console ↗
